Guide · The Ledger
Switching from research peptides to prescribed
A practical guide to the transition — including the awkward disclosure conversation, the humbling dose conversation, and the bloodwork you've been skipping.
This is a practical guide, not a lecture. If you've been self-sourcing research-grade peptides and you
want to move to a prescribed protocol, here's how that transition actually works — including the
parts that are awkward.
Step 1: Yes, tell them the truth
The awkward part, handled
You do not need to confess to a crime, because you haven't committed one — buying research-grade
peptides isn't illegal. But
you must disclose what you've actually been taking, at what dose, for
how long. A clinician who doesn't know you've been running 1mg of semaglutide weekly for four
months will start you at 0.25mg and you'll have wasted the titration — or worse, they'll miss an
interaction. Providers hear this constantly. It is not the disclosure you think it is.
Step 2: Expect the dose conversation to be humbling
Self-sourced protocols are frequently based on forum consensus rather than clinical guidance. A
prescriber may tell you your dose is too high, your cycle is too long, or the compound isn't doing what you
think. That's the value you're buying. If a provider simply rubber-stamps whatever you were already doing,
you've bought a script mill, not clinical oversight.
Step 3: Get the bloodwork you skipped
The single biggest gap in self-sourced protocols is the complete absence of baseline and follow-up labs.
Whatever else you do in this transition, get a baseline panel. Providers
like Hone Health and Marek
Health require it and build the protocol around it.
We earn nothing from this review
Veritide has no affiliate relationship with Hone Health. We reviewed it anyway — a provider comparison that only covers companies that pay us is a catalog, not a review. That is why there is no button here.
Read the full review →Step 4: Understand what you're paying for
| Research-grade | Prescribed |
|---|
| Cost per month | $40–$150 | $150–$400+ |
| What the extra buys | — | Clinician, 503A pharmacy, labs, accountability |
| Product verification | Vendor COA, if any | Pharmacy batch testing |
| If something goes wrong | You're alone | Named provider and pharmacy |
Prescribed is not cheaper. It's not supposed to be. You're buying oversight.
Step 5: Don't taper on your own initiative
If you're mid-protocol on a GLP-1, don't stop cold while you wait for your first prescribed shipment
— appetite rebound is real and the gap can undo months of progress. Time your intake so the
prescribed supply arrives before you run out, and let the clinician manage any dose transition.
FAQ
Do I have to tell a provider I've been using research peptides?
You should. Buying research-grade peptides isn't illegal, so you're not confessing to a crime. But a clinician who doesn't know your actual dose and duration will start you at a beginner dose or miss an interaction. Providers hear this constantly — it's a routine disclosure.
Will a provider prescribe the same dose I was already taking?
Not necessarily. A good prescriber may tell you your self-sourced dose is too high or your cycle too long. That reassessment is the thing you're paying for. A provider that rubber-stamps whatever you were doing is a script mill, not clinical oversight.
Should I stop my current protocol before starting prescribed?
Don't stop cold if you're mid-GLP-1 — appetite rebound is real. Time your intake so the prescribed supply arrives before your current supply runs out, and let the clinician manage the transition.
Medical disclaimer: Veritide is an independent consumer-research publication, not a healthcare provider or pharmacy. This page is informational and is not medical advice. Compounded medications are not FDA-approved as finished products. Always consult a licensed clinician before starting any peptide or GLP-1 therapy.